Filter
726
Filtered Results: 726
Text search:
World
Health
Organization
East
Mediterranean
Region
Featured
Recommendations
88
New Publications
146
Language
Document type
No document type
252
Studies & Reports
238
Guidelines
105
Manuals
41
Strategic & Response Plan
41
Fact sheets
16
Situation Updates
10
Resource Platforms
10
Training Material
8
Infographics
4
Online Courses
1
Countries / Regions
Global
82
Middle East and North Africa
23
Africa
22
Syria
21
Western and Central Europe
17
South–East Asia Region
10
Latin America and the Carribbean
9
Asia
7
West and Central Africa
7
India
7
Nigeria
6
East and Southern Africa
6
South Africa
6
Eastern Europe
5
Yemen
5
Myanmar / Burma
5
Pakistan
4
Kenya
3
Ghana
3
China
3
Iran
3
Afghanistan
3
Russia
3
Sudan
3
Libya
3
Iraq
3
Somalia
3
Nepal
2
Colombia
2
Thailand
2
Ukraine
2
Turkey
2
Sierra Leone
2
Albania
2
Philippines
2
Italy
2
USA
2
Cambodia
2
Jordan
2
Congo, Democratic Republic of
2
Western Pacific Region
2
Lebanon
2
Brazil
2
Ethiopia
2
South Sudan
2
Liberia
2
North Macedonia
1
Serbia
1
Benin
1
Rwanda
1
Cameroon
1
Niger
1
Malawi
1
Morocco
1
Guinea
1
Venezuela
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Tunisia
1
Bangladesh
1
Sri Lanka
1
Egypt
1
Greece
1
Georgia
1
Indonesia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
108
Countries
104
Public Health
79
Women & Child Health
58
Key Resources
42
Capacity Building
17
Pharmacy & Technologies
11
Toolboxes
Mental Health
79
COVID-19
65
Planetary Health
57
NTDs
43
Refugee
38
HIV
36
Global Health Education
34
Rapid Response
32
NCDs
32
TB
29
AMR
27
Caregiver
22
Conflict
22
Disability
18
Malaria
17
Pharmacy
16
Polio
12
Zika
9
Cholera
8
Ebola & Marburg
8
Health Financing Toolbox
8
2.0 Rapid Response
6
Natural Hazards
4
Specific Hazards
2
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide.
Last year, WHO laun...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Recommendations for a Public Health approach and considerations for policy-makers and managers
This practical manual is designed to support implementation of the World Health Organization (WHO) Guidelines on core components of infection prevention and control programmes at the national level, with special focus on countries with limited resources.
The Guidelines describe what is necessary ...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
Guidelines
Key Populations
Guidelines
HIV testing services
July 2015
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
Tobacco control legislation: an introductory guide
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
